Latest Histopathology Stories
Cambridge Laboratory Will Serve as Primary Location for Processing ProMark(TM), the Company's Newly-Launched Prostate Cancer Prognostic Test CAMBRIDGE, Mass., Dec.
DALLAS, December 6, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014" therapeutic market research
CAMBRIDGE, Mass., Nov.
WALNUT CREEK, Calif., Nov.
OWINGS MILLS, Md., Oct.
New Study Shows Link between Plaques and Tangles/Could Open Door to Therapeutic Target Boston (PRWEB) October 13, 2014 In what is being hailed by scientists
ProMark(TM) Validated to Predict Disease Aggressiveness and Empower Informed Treatment Decisions CAMBRIDGE, Mass., Oct.
- Webcast to Begin at 12:00 p.m.
-- Plans to Launch Lung Cancer Test In the Second Half of 2015, With Meaningful Revenue Expected in 2017 -- SOUTH SAN FRANCISCO, Calif., Sept.
SOUTH SAN FRANCISCO, Calif., Sept. 2, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.